BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22205303)

  • 21. [Expression and significance of alpha5beta1 integrin in abnormal scars].
    Yu Y; He GZ; Wu Y; Huang CB
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2004 Jul; 20(4):271-3. PubMed ID: 15568751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.
    Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y
    Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
    Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
    Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertrophic or keloid scars?
    McGrouther DA
    Eye (Lond); 1994; 8 ( Pt 2)():200-3. PubMed ID: 7958022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of TGF-β1 in keloids and hypertrophic scars.
    Abdou AG; Maraee AH; Al-Bara AM; Diab WM
    Am J Dermatopathol; 2011 Feb; 33(1):84-91. PubMed ID: 20559120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in Scar Biology.
    Ogawa R
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899255
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of transforming growth factor-beta1 antisense oligonucleotides on matrix metalloproteinases and their inhibitors in keloid fibroblasts.
    Bran GM; Goessler UR; Baftiri A; Hormann K; Riedel F; Sadick H
    Otolaryngol Head Neck Surg; 2010 Jul; 143(1):66-71. PubMed ID: 20620621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered expression of keratins during abnormal wound healing in human skin.
    Prathiba V; Rao KS; Gupta PD
    Cytobios; 2001; 104(405):43-51. PubMed ID: 11219730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insufficient expression of the melanocortin-1 receptor by human dermal fibroblasts contributes to excess collagen synthesis in keloid scars.
    Luo LF; Shi Y; Zhou Q; Xu SZ; Lei TC
    Exp Dermatol; 2013 Nov; 22(11):764-6. PubMed ID: 24433185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldosterone and mineralocorticoid receptor antagonists modulate elastin and collagen deposition in human skin.
    Mitts TF; Bunda S; Wang Y; Hinek A
    J Invest Dermatol; 2010 Oct; 130(10):2396-406. PubMed ID: 20535129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroproliferative scars.
    Rahban SR; Garner WL
    Clin Plast Surg; 2003 Jan; 30(1):77-89. PubMed ID: 12636218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated CD26 Expression by Skin Fibroblasts Distinguishes a Profibrotic Phenotype Involved in Scar Formation Compared to Gingival Fibroblasts.
    Mah W; Jiang G; Olver D; Gallant-Behm C; Wiebe C; Hart DA; Koivisto L; Larjava H; Häkkinen L
    Am J Pathol; 2017 Aug; 187(8):1717-1735. PubMed ID: 28641076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of keloid formation in humans and laboratory animals.
    Khorshid FA
    Med Sci Monit; 2005 Jul; 11(7):BR212-9. PubMed ID: 15990682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway.
    Liang CJ; Yen YH; Hung LY; Wang SH; Pu CM; Chien HF; Tsai JS; Lee CW; Yen FL; Chen YL
    Biochem Pharmacol; 2013 Jun; 85(11):1594-602. PubMed ID: 23500539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and function of sphingosine kinases 1 and 2 in human keloid fibroblasts].
    Zhang J; Xu B; Liu ZZ; Wang W; Wang LX; Zhang JX; Cai JL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):533-7. PubMed ID: 19567073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
    Sato M
    Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased production of MCP-1 and MMP-2 by keloid-derived fibroblasts.
    Yeh FL; Shen HD; Tai HY
    Burns; 2009 May; 35(3):348-51. PubMed ID: 18950946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS; Wu PH; Fang AH; Lan CC
    Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of caveolin-1 in the pathogenesis of tissue fibrosis by keloid-derived fibroblasts in vitro.
    Zhang GY; Yu Q; Cheng T; Liao T; Nie CL; Wang AY; Zheng X; Xie XG; Albers AE; Gao WY
    Br J Dermatol; 2011 Mar; 164(3):623-7. PubMed ID: 21375514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol inhibits fibrogenesis and induces apoptosis in keloid fibroblasts.
    Ikeda K; Torigoe T; Matsumoto Y; Fujita T; Sato N; Yotsuyanagi T
    Wound Repair Regen; 2013; 21(4):616-23. PubMed ID: 23815229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.